Literature DB >> 25550416

A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland.

James Rooney1, Susan Byrne1, Mark Heverin1, Katy Tobin1, Alison Dick2, Colette Donaghy2, Orla Hardiman1.   

Abstract

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a progressive debilitating neurodegenerative disease, with a life expectancy of 3-5 years from first symptom. There is compelling evidence that those who attend a multidisciplinary clinic experience improved survival. The purpose of the study was to explore the survival of patients with ALS ascertained through population-based Registers in the Republic of Ireland (RoI) and Northern Ireland (NI), and to determine whether centralisation of services confers advantage compared with community-based care supported by a specialist care worker.
METHODS: The island of Ireland is divided into two countries, RoI and NI, each with an independent healthcare system. Both countries have population-based ALS Registers with full ascertainment. Data from all 719 incident ALS cases from Ireland and NI, diagnosed between 1 January 2005 and 31 December 2010, were used in the analysis.
RESULTS: A survival benefit was identified for patients who attended the multidisciplinary ALS clinic in the RoI. (HR 0.59, 95% CI 0.49 to 0.71, p<0.001). This difference was preserved following multivariate analysis. A trend towards improved survival was noted for patients with ALS from NI when compared with RoI patients who did not attend a multidisciplinary clinic.
CONCLUSIONS: Centralised multidisciplinary care confers a survival advantage for patients with ALS and is superior to devolved community-based care. We propose that multiple decision-making processes within a multidisciplinary setting lead to an enriched set of clinical encounters for the patient and carer that enhances clinical outcome. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  ALS; EPIDEMIOLOGY; MOTOR NEURON DISEASE

Mesh:

Year:  2014        PMID: 25550416     DOI: 10.1136/jnnp-2014-309601

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  52 in total

1.  Riluzole and other prognostic factors in ALS: a population-based registry study in Italy.

Authors:  Jessica Mandrioli; Sara Angela Malerba; Ettore Beghi; Nicola Fini; Antonio Fasano; Elisabetta Zucchi; Silvia De Pasqua; Carlo Guidi; Emilio Terlizzi; Elisabetta Sette; Alessandro Ravasio; Mario Casmiro; Fabrizio Salvi; Rocco Liguori; Lucia Zinno; Yasmin Handouk; Romana Rizzi; Annamaria Borghi; Rita Rinaldi; Doriana Medici; Mario Santangelo; Enrico Granieri; Vittoria Mussuto; Marina Aiello; Salvatore Ferro; Marco Vinceti
Journal:  J Neurol       Date:  2018-02-05       Impact factor: 4.849

2.  Factors predicting survival in ALS: a multicenter Italian study.

Authors:  Andrea Calvo; Cristina Moglia; Christian Lunetta; Kalliopi Marinou; Nicola Ticozzi; Gianluca Drago Ferrante; Carlo Scialo; Gianni Sorarù; Francesca Trojsi; Amelia Conte; Yuri M Falzone; Rosanna Tortelli; Massimo Russo; Adriano Chiò; Valeria Ada Sansone; Gabriele Mora; Vincenzo Silani; Paolo Volanti; Claudia Caponnetto; Giorgia Querin; Maria Rosaria Monsurrò; Mario Sabatelli; Nilo Riva; Giancarlo Logroscino; Sonia Messina; Nicola Fini; Jessica Mandrioli
Journal:  J Neurol       Date:  2016-10-24       Impact factor: 4.849

3.  The evaluation of bulbar dysfunction in amyotrophic lateral sclerosis: survey of clinical practice patterns in the United States.

Authors:  Emily K Plowman; Lauren C Tabor; James Wymer; Gary Pattee
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-04-20       Impact factor: 4.092

4.  Discriminant ability of the Eating Assessment Tool-10 to detect aspiration in individuals with amyotrophic lateral sclerosis.

Authors:  E K Plowman; L C Tabor; R Robison; J Gaziano; C Dion; S A Watts; T Vu; C Gooch
Journal:  Neurogastroenterol Motil       Date:  2015-10-28       Impact factor: 3.598

Review 5.  Supportive and symptomatic management of amyotrophic lateral sclerosis.

Authors:  Esther V Hobson; Christopher J McDermott
Journal:  Nat Rev Neurol       Date:  2016-08-12       Impact factor: 42.937

6.  Canadian best practice recommendations for the management of amyotrophic lateral sclerosis.

Authors:  Christen Shoesmith; Agessandro Abrahao; Tim Benstead; Marvin Chum; Nicolas Dupre; Aaron Izenberg; Wendy Johnston; Sanjay Kalra; Desmond Leddin; Colleen O'Connell; Kerri Schellenberg; Anu Tandon; Lorne Zinman
Journal:  CMAJ       Date:  2020-11-16       Impact factor: 8.262

7. 

Authors:  Christen Shoesmith; Agessandro Abrahao; Tim Benstead; Marvin Chum; Nicolas Dupre; Aaron Izenberg; Wendy Johnston; Sanjay Kalra; Desmond Leddin; Colleen O'Connell; Kerri Schellenberg; Anu Tandon; Lorne Zinman
Journal:  CMAJ       Date:  2020-11-16       Impact factor: 8.262

8.  Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival.

Authors:  R M Ahmed; J Caga; E Devenney; S Hsieh; L Bartley; E Highton-Williamson; E Ramsey; M Zoing; G M Halliday; O Piguet; J R Hodges; M C Kiernan
Journal:  J Neurol       Date:  2016-06-03       Impact factor: 4.849

Review 9.  Motor neuron disease: biomarker development for an expanding cerebral syndrome.

Authors:  Martin R Turner
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

10.  Patient-reported problematic symptoms in an ALS treatment trial.

Authors:  Divisha Raheja; Helen E Stephens; Erik Lehman; Susan Walsh; Chengwu Yang; Zachary Simmons
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-01-29       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.